Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · IEX Real-Time Price · USD

5.56

-0.01 (-0.18%)

At close: Jul 19, 2024, 4:00 PM

5.57

+0.01 (0.18%)

Pre-market: Jul 22, 2024, 4:01 AM EDT

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Revenue	191.41	175.51	134.03	45.61	50.12	0.32	Upgrade
Revenue Growth (YoY)	30.37%	30.95%	193.89%	-9.00%	15660.38%	-31.32%	Upgrade
Cost of Revenue	21.48	14.15	5.66	1.09	0	0	Upgrade
Gross Profit	169.93	161.37	128.37	44.51	50.12	0.32	Upgrade
Selling, General & Admin	192.61	195.04	196.37	173.54	97.27	22.34	Upgrade
Research & Development	42.03	49.64	44.99	51.14	50.33	52.87	Upgrade
Other Operating Expenses	10.65	8.38	-1.52	0.57	6.81	16.06	Upgrade
Operating Expenses	245.29	253.06	239.84	225.25	154.41	91.26	Upgrade
Operating Income	-75.36	-91.69	-111.47	-180.74	-104.29	-90.94	Upgrade
Interest Expense / Income	4.06	2.78	0	0	0	0	Upgrade
Other Expense / Income	-17.71	-17	-5.12	-0.53	-1.52	-2.7	Upgrade
Pretax Income	-61.71	-77.47	-106.35	-180.21	-102.77	-88.24	Upgrade
Income Tax	0.85	0.55	1.83	0.76	-0.09	0.14	Upgrade
Net Income	-62.56	-78.02	-108.18	-180.97	-102.68	-88.39	Upgrade
Shares Outstanding (Basic)	144	143	142	129	118	93	Upgrade
Shares Outstanding (Diluted)	144	143	142	129	118	93	Upgrade
Shares Change	0.96%	0.93%	9.70%	9.20%	27.36%	9.72%	Upgrade
EPS (Basic)	-0.42	-0.54	-0.76	-1.40	-0.87	-0.95	Upgrade
EPS (Diluted)	-0.42	-0.54	-0.76	-1.40	-0.87	-0.95	Upgrade
Free Cash Flow	-20.61	-34.18	-79.82	-159.19	-77.2	-63.69	Upgrade
Free Cash Flow Per Share	-0.14	-0.24	-0.56	-1.23	-0.65	-0.69	Upgrade
Gross Margin	88.78%	91.94%	95.77%	97.61%	100.00%	100.00%	Upgrade
Operating Margin	-39.37%	-52.24%	-83.17%	-396.31%	-208.09%	-28598.43%	Upgrade
Profit Margin	-32.69%	-44.45%	-80.71%	-396.81%	-204.88%	-27794.03%	Upgrade
Free Cash Flow Margin	-10.77%	-19.47%	-59.55%	-349.07%	-154.04%	-20027.04%	Upgrade
EBITDA	-41.87	-63.05	-103.65	-177.45	-101.4	-87.07	Upgrade
EBITDA Margin	-21.88%	-35.92%	-77.33%	-389.09%	-202.33%	-27380.50%	Upgrade
Depreciation & Amortization	15.78	11.65	2.71	2.76	1.37	1.17	Upgrade
EBIT	-57.65	-74.69	-106.35	-180.21	-102.77	-88.24	Upgrade
EBIT Margin	-30.12%	-42.56%	-79.35%	-395.15%	-205.06%	-27748.74%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).